ODI PHARMA AB Cash Flow Quality Index

Latest as of June 2026: 2.38x

ODI PHARMA AB cash flow quality index. ODI PHARMA AB (6OD) has a Cash Flow Quality Index of 2.38x as of June 2026. Operating cash flow of €364.19K exceeds net income of €153.04K, indicating high earnings quality where cash backs reported profits. See ODI PHARMA AB (6OD) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

2.38x
Operating CF / Net Income

Operating Cash Flow

€364.19K
EUR

Net Income

€153.04K
EUR

Data as of

Jun 2026
Most recent filing

Cash Flow Quality Index of ODI PHARMA AB (2026–2026)

Cash flow quality index of ODI PHARMA AB from 2026 to 2026. Historical Cash Flow Quality Index for ODI PHARMA AB across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore ODI PHARMA AB (6OD) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

ODI PHARMA AB Cash Flow Quality Index by Year (2026–2026)

ODI PHARMA AB cash flow quality index by year from 2026 to 2026. Year-by-year earnings quality comparison for ODI PHARMA AB. For the full cash flow conversion analysis, see how efficiently does ODI PHARMA AB generate cash.

Year Quality Index Operating CF (EUR) Net Income YoY Change
2026 2.30x €4.58 Million €1.99 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.